Summary

Data Monetization Solutions For Life Science Companies Market Growth & Trends

The global data monetization solutions for life science companies market size is anticipated to reach USD 976.0 million by 2030, according to a new study by Grand View Research, Inc. The market is projected to grow at a CAGR of 16.2% from 2023 to 2030. The data monetization solutions market for life science companies is rapidly evolving, driven by the increasing recognition of data as a valuable asset and the surge in healthcare digitization. Life science firms embrace data monetization strategies to leverage their vast data repositories effectively. This involves extracting, analyzing, and strategically using data to derive actionable insights, enhance decision-making, and generate additional revenue streams.

Moreover, the emergence of stringent data protection regulations, such as the General Data Protection Regulation (GDPR) in Europe and the California Consumer Privacy Act (CCPA) in the U.S., has significantly increased demands on businesses handling personal data. These regulatory frameworks necessitate robust protection of customer data and empower individuals with greater authority over their data usage. This shift is poised to drive forward more innovative and customer-centric approaches to data monetization in the foreseeable future.

Strategic initiatives by key companies operating in the market enhance their capabilities through acquisitions and the launch of advanced solutions, which can potentially drive market growth for data monetization solutions in the life science sector. For instance, In February 2022, Managed Markets Insight & Technology (MMIT) unveiled Patient Access Analytics. This innovative solution empowers pharmaceutical commercial teams by enabling quick analysis and visualization of various longitudinal, real-world patient datasets. It facilitates immediate access to crucial insights pertaining to access challenges and prescribing trends.

However, this industry transformation is accompanied by challenges such as stringent data privacy regulations, interoperability issues, and the need for advanced analytics capabilities. Overcoming these obstacles while harnessing the potential of data monetization remains pivotal for life science enterprises' sustained growth and competitiveness in today's data-driven landscape.

Data Monetization Solutions For Life Science Companies Market Report Highlights

• Based on type, the software segment held the largest revenue share of 57.1% of the market in 2022 and it is expected to continue its dominance with the fastest growth rate over the forecast period. This is owing to its scalability and flexibility, allowing healthcare providers to adapt to evolving data needs and integrate seamlessly with existing healthcare systems

• In terms of enterprise size, the large enterprises segment dominated the market in 2022 with the largest revenue share of 54.01%. This is owing to its substantial resources, technological capabilities, and extensive networks. These enterprises often possess the financial strength to invest significantly in advanced data monetization solutions, enabling them to use vast amounts of data efficiently

• In terms of region, North America has dominated the market in 2022 with the largest revenue share of 41.17%, owing to its well-established and technologically advanced healthcare ecosystem. The region has mature markets, a strong regulatory framework, and a culture of early technology adoption

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing use of external data sources
3.2.1.2. Digital transformation in the healthcare sector
3.2.1.3. Rising enterprise data volumes
3.2.2. Market Restraint Analysis
3.2.2.1. Data privacy and security concerns
3.2.2.2. Regulatory constraints
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Data Monetization Solutions for Life Science Companies Market: Type Movement Analysis
4.2. Software
4.2.1. Software Market, 2018 - 2030 (USD Million)
4.3. Services
4.3.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Enterprise Size Business Analysis
5.1. Data Monetization Solutions for Life Science Companies Market: Enterprise Size Movement Analysis
5.2. Small & Medium Enterprises
5.2.1. Small & Medium Enterprises Market, 2018 - 2030 (USD Million)
5.3. Large Enterprises
5.3.1. Large Enterprises Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Data Monetization Solutions for Life Science Companies Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Regulatory Framework
6.2.3.3. U.S. Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Regulatory Framework
6.2.4.3. Canada Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Regulatory Framework
6.3.2.3. UK Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Regulatory Framework
6.3.3.3. Germany Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Regulatory Framework
6.3.4.3. France Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Regulatory Framework
6.3.5.3. Italy Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Regulatory Framework
6.3.6.3. Spain Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Regulatory Framework
6.3.7.3. Denmark Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Regulatory Framework
6.3.8.3. Sweden Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Regulatory Framework
6.3.9.3. Norway Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Japan Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. China Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. India Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Regulatory Framework
6.4.5.3. Australia Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Regulatory Framework
6.4.6.3. Thailand Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Regulatory Framework
6.4.7.3. South Korea Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.4.8. Singapore
6.4.8.1. Key Country Dynamics
6.4.8.2. Regulatory Framework
6.4.8.3. Singapore Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Brazil Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Mexico Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Argentina Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. South Africa Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Saudi Arabia Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. UAE Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Kuwait Data Monetization Solutions for Life Science Companies Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Categorization
7.1.1. Oracle
7.1.1.1. Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Microsoft
7.1.2.1. Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Google
7.1.3.1. Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Salesforce, Inc.
7.1.4.1. Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. SAP
7.1.5.1. Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. SAS Institute, Inc.
7.1.6.1. Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Accenture.
7.1.7.1. Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Infosys Limited
7.1.8.1. Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Cisco Systems
7.1.9.1. Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Siemens
7.1.10.1. Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Particle Health, Inc.
7.1.11.1. Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
7.1.12. Snowflake Inc.
7.1.12.1. Overview
7.1.12.2. Financial Performance
7.1.12.3. Product Benchmarking
7.1.12.4. Strategic Initiatives
7.2. Strategy Mapping
7.2.1. Expansion
7.2.2. Acquisition
7.2.3. Product/Service Launch
7.2.4. Others